Sansec(688489)2025-04-24 13:35Financial Performance - The company's revenue for Q1 2025 was CNY 65,530,690.26, representing a 32.70% increase compared to CNY 49,382,475.44 in the same period last year[5]. - The net profit attributable to shareholders was a loss of CNY 34,011,422.49, worsening from a loss of CNY 9,966,079.70 year-on-year[5]. - Total operating revenue for Q1 2025 reached ¥65,530,690.26, a 32.7% increase from ¥49,382,475.44 in Q1 2024[20]. - Net loss for Q1 2025 was ¥36,296,846.19, compared to a net loss of ¥11,012,489.91 in Q1 2024, indicating a significant increase in losses[21]. - Basic earnings per share for Q1 2025 were -¥0.2963, compared to -¥0.0878 in Q1 2024[21]. Research and Development - Research and development expenses totaled CNY 39,543,665.23, an increase of 49.13% from CNY 26,517,064.53 in the previous year[6]. - R&D expenses accounted for 60.34% of total revenue, up from 53.70% in the previous year, indicating a 6.64 percentage point increase[6]. - Research and development expenses for Q1 2025 were ¥39,543,665.23, compared to ¥26,517,064.53 in Q1 2024, reflecting a 49.2% increase[20]. Cash Flow and Liquidity - The net cash flow from operating activities was a negative CNY 74,073,441.32, slightly improved from a negative CNY 76,676,815.40 in the previous year[5]. - In Q1 2025, the cash inflow from operating activities was CNY 132,549,112.17, a significant increase from CNY 69,336,227.57 in Q1 2024, representing an increase of approximately 91%[23]. - The net cash outflow from operating activities was CNY -74,073,441.32, slightly improved from CNY -76,676,815.40 in the previous year[23]. - The company reported a total cash outflow from operating activities of CNY 206,622,553.49 in Q1 2025, compared to CNY 146,013,042.97 in Q1 2024, an increase of approximately 42%[23]. - The ending cash and cash equivalents balance decreased to CNY 623,704,484.87 from CNY 1,062,959,298.06 year-over-year, a decline of approximately 41%[24]. Assets and Liabilities - Total assets decreased by 5.59% to CNY 2,058,716,121.51 from CNY 2,180,570,484.94 at the end of the previous year[6]. - Total liabilities amounted to ¥185,883,834.74, down from ¥272,710,881.34 in the previous period[17]. - Total equity decreased to ¥1,872,832,286.77 from ¥1,907,859,603.60[17]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 5,277[11]. - The largest shareholder, Zhang Yuegong, holds 20.64% of the shares, totaling 23,692,852 shares[11]. - The top ten shareholders include significant institutional investors, with the largest being Jiangxi Yurun Lida Equity Investment Management holding 9,671,800 shares, or 8.43%[12]. - The company has a total of 2,378,000 shares held in the repurchase account, accounting for 2.07% of the total share capital[12]. Operational Insights - The company attributed the revenue growth to significant increases in orders from key industry clients and the consolidation effects from the acquisition of Jiangnan Tianan[8]. - The increase in costs and expenses was primarily due to heightened investments in R&D and sales personnel, as well as the impact of the Jiangnan Tianan acquisition[8]. - The company is focusing on expanding its market presence and enhancing product development strategies to improve future performance[22].